Protein expression of the hepatic CYP2E1 has been reported to be increased in diabetic rats. This enzyme is the primary metabolizer of chlorozoxazone (CZX) to 6-hydroxychlorzoxazone (OH-CZX). Although patients with liver cirrhosis have a higher prevalence of diabetes mellitus, there have no reported studies on the protein expression of CYP2E1 in rats induced to have liver cirrhosis and diabetes mellitus by injection of N-dimethylnitrosamine followed by streptozotocin (LCD rats). Thus, in the present study, the pharmacokinetics of CZX and OH-CZX were evaluated in LCD rats. Compared with control rats, LCD rats had significantly decreased (by 62%) total liver protein and significantly increased (by 124%) protein expression of CYP2E1, but the intrinsic clearance (Cl int ; formation of OH-CZX per mg protein) was comparable in both groups of rats. As a result, the relative Cl int was also comparable for the two groups. Thus, OH-CZX formation in LCD and control rats was expected to be similar. As expected, after intravenous (20 mg/kg) and oral (50 mg/kg) administration of CZX, the AUC of OH-CZX was comparable in control and LCD rats (intravenous, 571 ± 85.8 and 578 ± 413 µg • min/ml, respectively; oral, 1540 ± 338 and 2170 ± 1070 µg • min/ml, respectively). In LCD rats, the AUC OH-CZX / AUC CZX ratio was similar to value in control rats after intravenous and oral administration. These results indicate that OH-CZX can be used as a chemical probe to assess the activity of CYP2E1 in LCD rats.
Induction of Liver Cirrhosis (LC) in Rats by N-Dimethylnitrosamine Injection. Freshly prepared N-dimethylnitrosamine (diluted to 0.01 mg/ml in 0.9% NaCl injectable solution) was injected intraperitoneally at a dose of 0.01 mg/kg on three consecutive days per week for four weeks (Ohara and Kusano, 2002; . On day 29, citrate buffer (pH 7.4; 1 ml/kg) was injected via the tail vein. On day 36, rats were treated with CZX.
Laboratory rats with N-dimethylnitrosamine-induced liver cirrhosis have clinical features similar to those of humans with liver cirrhosis, such as increased mortality, hepatic parenchymal cell destruction, formation of connective tissue, and nodular regeneration (Kang et al., 2002) .
Liver cirrhosis in the LC rats was evident by histological analysis, which revealed extensive micronodular cirrhosis with regenerative hepatocellular changes. Bile ductular proliferation was also detected . It has been reported that N-dimethylnitrosamine-induced liver cirrhosis in rats is reproducible (Jenkins et al., 1985; Jezequel et al., 1987) .
Induction of Diabetes Mellitus (DM) in Rats by Streptozotocin Injection.
A 0.9% NaCl injectable solution was injected intraperitoneally (1 ml/kg) on three consecutive days a week for four weeks. On day 29, one dose (45 mg/kg) of freshly prepared streptozotocin [dissolved in citrate buffer (pH 4.5) to 45 mg/ml] was administered via the tail vein (Kim et al., 2005) . The rats were treated with CZX on day 36.
Induction of Liver Cirrhosis with Diabetes Mellitus (LCD) in Rats with
N-Dimethylnitrosamine and Streptozotocin Injections. Liver cirrhosis was induced by intraperitoneal injection of N-dimethylnitrosamine as described above. Then, on day 29, diabetes mellitus was induced by injection of streptozotocin via the tail vein as described above. The rats This article has not been copyedited and formatted. The final version may differ from this version. Control Rats. Rats were injected intraperitoneally with 0.9% NaCl injectable solution (1 ml/kg) on three consecutive days a week for four weeks. On day 29, one dose (1 ml/kg) of citrate buffer (pH 4.5) was administered via the tail vein. The rats were treated with CZX on day 36.
During the pretreatment, food and water were available ad libitum to all rats. Immediately before the experiment, blood glucose levels in all rats were measured using the Medisense Optium kit (Abbott Laboratories, Bradford, MA), and rats with blood glucose levels greater than 250 mg/dl were selected as diabetic (DM and LCD rats).
Measurement of Liver, Kidney, and Spleen Function. To assess liver, kidney, and spleen function, a 24-h urine sample was collected on day 36 from LC, DM, LCD, and control rats (n = 6, each) for the measurement of creatinine levels. A blood sample was collected from the carotid artery for the measurement of the hematocrit (Microprocessor pH/°C Meter; Eutek Cybernetics, Singapore, Singapore). The plasma was measured for the total protein, albumin, urea nitrogen, glutamate oxaloacetate transaminase (GOT), glutamate pyruvate transaminase (GPT), total bilirubin, direct bilirubin, alkaline phosphatase (ALP), lactate dehydrogenase (LDH), and creatinine by the Green Cross Reference Laboratory (Seoul, South Korea). Plasma protein binding of CZX was measured using equilibrium dialysis (Shim et al., 2000) .
The whole liver, kidney, and spleen of each rat were excised, rinsed with 0.9% NaClinjectable solution, blotted dry with tissue paper, and weighed. Small portions of each organ were fixed in 10% neutral phosphate-buffered formalin and then processed for routine histological examination with hematoxylin and eosin staining. Each rat was exsanguinated and sacrificed by cervical dislocation.
Preparation of Hepatic Microsomes. The procedures used were similar to those described by Baek et al. (2006) . Livers from LC, DM, LCD, and control rats (n = 5, each) were This article has not been copyedited and formatted. The final version may differ from this version. homogenized (Ultra-Turrax T25; Janke and Kunkel, IKA-Labortechnik, Staufeni, Germany) in ice-cold homogenization buffer (0.154 M KCl/50 mM Tris-HCl in 1 mM EDTA, pH 7.4). After the homogenate was centrifuged (10,000 × g, 30 min), the supernatant fraction was removed and centrifuged at high speed (100,000 × g, 90 min). The resulting microsomal pellet was resuspended in homogenization buffer and stored at -70°C (Revco ULT 1490 D-N-S; Western Mednics, Asheville, NC) until used. Protein content was measured using the Bradford method (Bradford, 1976) .
Western immunoblot Analysis of CYP2E1.
The procedures used were similar to a reported method . Liver microsomes were resolved by SDS gel electrophoresis on a 7.5% polyacrylamide gel (10 µg protein per lane; n = 3, each). Proteins were transferred to a nitrocellulose membrane (Bio-Rad Laboratories) that was then blocked for 1 h in 5% milk powder in phosphate-buffered saline containing 0.05% (v/v) Tween 20 (PBS-T). For immunodetection, blots were incubated overnight at 4°C with rabbit anti-human CYP2E1 antibody (diluted 1:10,000 in PBS-T containing 5% bovine serum albumin), followed by incubation for 1 h at room temperature with horseradish peroxidase-conjugated goat anti-rabbit secondary antibody (diluted 1:10,000 in PBS-T containing 5% milk powder). Protein expression of CYP2E1 was detected by enhanced chemiluminescence on Kodak X-OMAT film and quantitated by densitometry with a microcomputer imaging device (model M1; Imaging Research, St. Catharines, Ontario, Canada). The β -actin band was used as a loading control.
Measurement of V max , K m , and Cl int for the Formation of OH-CZX in Hepatic
Microsomes. Microsomal fractions (equivalent to 0.2 mg protein) were mixed with 50 µl of 0.1 M phosphate buffer (pH 7.4) containing 1 mM NADPH; 10 µl of CZX dissolved in a minimal amount of 10 N NaOH to make final concentrations of 2. 5, 5, 10, 20, 50, 100, 200, 500 , and 1000 mM CZX; and 0.1 M phosphate buffer (pH 7.4) sufficient to make a final volume of 0.5 ml. This reaction mixture was incubated in a water-bath shaker [37°C, 50 oscillations per minute (opm)]
This article has not been copyedited and formatted. The final version may differ from this version. for 20 min, at which time the reaction was terminated by addition of 1 ml of ether. The formation of OH-CZX was determined using an HPLC method (Frye and Stiff, 1996) . The kinetic parameters (K m , V max ) for the formation of OH-CZX were determined by fitting the unweighted kinetic data from rat liver microsomes to a single-site Michaelis-Menten equation:
where [S] is the substrate concentration. The best-fit model was selected based on the statistical goodness of fit (Yamaoka et al., 1978) ; the model with the lowest AIC (Akaike Information anesthesia for 4 to 5 h before beginning the experiment. Thus, the rats were not restrained in the present study. Ketamine was employed instead of ether to minimize the effect on CYP2E1, since Liu et al. (1993) reported that ether anesthesia alone increased the protein expression of CYP2E1
by 40%, as determined by assaying p-nitrophenol hydroxylase activity.
Intravenous Study. CZX (dissolved in a minimum amount of 10 N NaOH) at a dose of 20 mg/kg was infused (total infusion volume of 2 ml/kg) over 1 min via the jugular vein to rats in each group (n = 9, 7, 7, and 8 for LC, DM, LCD, and control rats, respectively). A blood sample (approximately 0.12 ml) was collected via the carotid artery at 0 (control), 1 (at the end of the infusion), 5, 15, 30, 45, 60, 90, 120 , and 180 min after the start of the intravenous infusion of CZX.
A heparinized 0.9% NaCl injectable solution (20 units/ml; 0.3 ml) was used to flush the cannula immediately after each blood sampling to prevent clotting.
Each blood sample was immediately centrifuged, and a 50-µl aliquot of plasma was stored at -70°C for later analysis of CZX and OH-CZX by HPLC (Frye and Stitt, 1996) . At the end of the experiment (24 h after CZX treatment), each metabolic cage was rinsed with 20 ml of distilled water, and the rinse water was combined with the 24-h urine sample. The volume of the combined urine sample was determined, and two 50-µl aliquots were stored at -70°C for later analysis. At the same time (24 h), as much blood as possible was collected via the carotid artery, and each rat was sacrificed by cervical dislocation. Then, the abdomen was opened, and the entire gastrointestinal tract (including its contents and feces) of each rat was removed, transferred to a beaker containing 50 ml of 0.1 N NaOH (to facilitate the extraction of CZX and OH-CZX), and cut into small pieces with scissors. After stirring with a glass rod for 1 min, two 50-µl aliquots of the supernatant were collected from each beaker and stored at -70°C for later analysis.
Oral Study. CZX (the same solution used in the intravenous study) at a dose of 50 mg/kg was administered orally (total oral volume of 3 ml/kg) using a feeding tube to rats in each group (n = This article has not been copyedited and formatted. The final version may differ from this version. 15, 30, 45, 60, 90, 120, 180, 240, 360 , and 480 min after oral administration of CZX. Other procedures were similar to those described above for the intravenous study.
Measurement of Rat Plasma Protein Binding of CZX Using Equilibrium Dialysis.
Binding of CZX to protein in fresh plasma from LC, DM, LCD, and control rats (n = 5, each) was measured using equilibrium dialysis (Shim et al., 2000) . Plasma (1 ml) was dialyzed against 1 ml of isotonic Sørensen phosphate buffer (pH 7.4) containing 3% (w/v) dextran to minimize volume shift (Boudinot and Jusko, 1984) in a 1-ml dialysis cell (Fisher Scientific, Fair Lawn, NJ) fitted with a Spectra/Por 4 membrane (molecular weight cutoff of 12-14 kDa; Spectrum Medical Industries Inc., Los Angeles, CA). The initial concentrations of CZX spiked into the plasma compartment were 1, 10, and 50 µg/ml. After a 24-h incubation, two 50-µl aliquots were removed from each compartment and stored at -70°C for later HPLC analysis of CZX.
HPLC Analysis of CZX and OH-CZX.
Concentrations of CZX and OH-CZX in the samples were determined using an HPLC method (Frye and Stiff, 1996) . Briefly, a 0.1-ml aliquot of 0.2 M sodium acetate buffer (pH 4.75) and a 0.1-ml aliquot of isotonic Sørensen phosphate buffer (pH 7.4) containing 200 units of β -glucuronidase were added to 50 µl of sample. The mixture was mixed manually and incubated in a water-bath shaker (50 opm) for 2 h at 37°C. A 50-µl aliquot of methanol containing 10 mg/ml of 3-aminophenyl sulfone (internal standard) was then added. After the mixture was vortexed, 1 ml of diethyl ether was added, and the mixture was shaken for 10 min. After centrifugation (16,000 × g, 10 min), the upper organic layer was transferred to a clean tube and dried (Dry Thermobath; Eyela, Tokyo, Japan) under a gentle stream of nitrogen gas at 37°C. CZX were approximately 6, 10, and 18 min, respectively. The detection limit for CZX and OH-CZX in the rat plasma and urine samples was all 0.05 µg/ml. The coefficients of variation of the assay (within-and between-day) were less than 8.2%.
Pharmacokinetic Analysis. The AUC was calculated using the trapezoidal rule-extrapolation method (Chiou, 1978) . The area from the last datum point to time infinity was estimated by dividing the last measured plasma concentration by the terminal-phase rate constant.
Standard methods (Gibaldi and Perrier, 1982) were used to calculate the following pharmacokinetic parameters, using a non-compartmental analysis (WinNonlin; Pharsight Corporation, Mountain View, CA): the time-averaged total body, renal, and non-renal clearances (Cl, Cl r , and Cl nr , respectively), the terminal half-life (t 1/2 ), the first moment of AUC (AUMC), the mean residence time (MRT), the apparent volume of distribution at steady state (V ss ), and the extent of absolute oral bioavailability (F). The peak plasma concentration (C max ) and the time to reach C max (T max ) were directly read from the experimental data.
Statistical Analysis. A p-value < 0.05 was deemed to be statistically significant using an unpaired t-test or a Duncan's multiple range test, with the Statistical Package for the Social Sciences (SPSS) posteriori analysis of variance (ANOVA) among the four means for the unpaired data. All data are expressed as the mean ± standard deviation (S.D.), with the exception of T max , which is expressed as the median (range).
This article has not been copyedited and formatted. The final version may differ from this version. (Mitruka and Rawnsley, 1981; Davies and Morris, 1993) are also shown.
Compared with the control rats, the LC rats had significantly decreased 24-h urine volume and plasma levels of total protein and albumin; significantly increased plasma levels of GOT, GPT, total bilirubin, direct bilirubin, alkaline phosphatase, and total cholesterol; significantly decreased relative liver weight; and significantly increased relative spleen weight. In DM rats, the blood glucose level, the 24-h urine output, the plasma levels of GPT, alkaline phosphatase, urea nitrogen, and total cholesterol, and the relative kidney weight were significantly increased, compared with the control rats. In LCD rats, the blood glucose level, the plasma levels of total protein and albumin, the 24-h urine output, and the relative liver weight were significantly decreased compared with the control rats, whereas the plasma levels of GOT, GPT, total bilirubin, direct bilirubin, alkaline phosphatase, LDH, urea nitrogen, and total cholesterol and the relative kidney and spleen weights were significantly increased. However, the Cl cr did not differ significantly among the four groups.
These findings suggest that in LC and LCD rats, neither kidney nor spleen function was seriously impaired, whereas liver function was somewhat impaired. Consistent with this result, no significant histological findings were detected in the liver, kidney, or spleen in any rats, except that extensive hepatocellular degeneration with bridging fibrosis (pre-cirrhotic change) was detected in the livers of LC and LCD rats.
Protein expression of CYP2E1. Compared with the control rats, the protein expression of This article has not been copyedited and formatted. The final version may differ from this version. Table 2 . For the LCD rats, the V max for OH-CZX formation was significantly lower than that of the DM rats (by 39.7%) and higher than that of the LC rats (by 289%), but was similar to value observed in control rats. The changes oveserved in the V max reflect the changes observed in the amount of CYP2E1 (Table 2 ). This result suggests that in LCD rats, the maximum velocity for the formation of OH-CZX was similar to value observed in control rats. However, the K m for the formation of OH-CZX was comparable (not significantly different) among the four groups of rats, indicating that the affinity of the enzyme(s) for CZX was not changed. As a result, in LCD rats, the Cl int for the formation of OH-CZX per mg protein was significantly slower than in DM rats (by 53.6%) and faster than in LC rats (by 197%), but was similar to value observed in control rats. The total protein was significantly lower in LCD rats than in control or DM rats, but it was comparable to that in LC rats.
As discussed above (Fig. 1) , the protein expression of CYP2E1 differed significantly among the four groups. Because the relative liver weight, total protein per whole liver, and protein contents of CYP2E1 were not comparable among the four groups, the relative Cl int for the formation of OH-CZX, based on total liver protein, was calculated; in LCD rats, the value was considerably higher (by 353%) than that in LC rats and lower (by 82.4%) than that in DM rats, but was similar to value observed in control rats. This result suggests that in LCD rats, the formation of OH-CZX, based on the whole liver, may be comparable to that in control rats and that the V max , This article has not been copyedited and formatted. The final version may differ from this version. plasma from the four groups of rats were 73.0 ± 4.96% (control), 62.5 ± 8.53% (LC), 67.1 ± 2.44% (DM), and 72.3 ± 2.23% (LCD), respectively; the value in LC rats was significantly lower than that in control and LCD rats. Protein binding of CZX to plasma from control rats (n = 3, each)
was constant for CZX concentrations of 1, 10, and 50 µg/ml, which yielded values of 68.3 ± 3.51, 69.6 ± 1.91, and 67.3 ± 5.44%, respectively. Thus, a CZX concentration of 10 µg/ml was arbitrarily chosen for the plasma protein binding studies.
Pharmacokinetics of CZX and OH-CZX after Intravenous Administration of CZX.
The mean arterial plasma CZX concentration-time profiles for intravenous administration of CZX (20 mg/kg) to LC, DM, LCD, and control rats are shown in Fig. 3A , and the relevant pharmacokinetic parameters are listed in Table 3 . In LC rats, the AUC of CZX was significantly greater, the terminal t 1/2 and MRT were significantly longer, and the Cl, Cl r , and Cl nr were significantly lower than those in control rats. In DM rats, the AUC was significantly smaller, the terminal t 1/2 was significantly shorter, and the Cl, Cl r , and Cl nr were significantly faster than those in control rats.
Interestingly, the AUC, MRT, Cl, Cl r , and Cl nr of CZX were similar between LCD and control rats.
The contribution of the Cl r to the Cl of CZX was almost negligible; the values were less than 3.63% in all rats studied. However, the V ss of CZX and the percentage of the intravenous dose of This article has not been copyedited and formatted. The final version may differ from this version. CZX excreted in the 24-h urine as unchanged drug (Ae 0-24 h ) were not significantly different among the four groups. CZX was undetectable (under the detection limit) in the gastrointestinal tract at 24 h (GI 24 h ) in all rats. Thus, the contribution of changes in the Cl r of CZX to other pharmacokinetic changes of CZX may also be almost negligible.
For the intravenous administration of CZX to DM, LC, LCD, and control rats, the mean arterial plasma OH-CZX concentration-time profiles are shown in Fig. 3B , and the relevant pharmacokinetic parameters are shown in Table 3 . Formation of OH-CZX was rapid; for all four groups of rats, OH-CZX was detected in plasma at the first blood sampling time (1 min), and it rapidly reached T max within 5-60 min. In LC rats, the AUC of OH-CZX was significantly smaller, the C max was significantly lower, the T max was significantly longer, the Ae 0-24 h of total OH-CZX was significantly smaller, and AUC OH-CZX /AUC CZX ratio was significantly smaller than those in controls. In DM rats, the AUC of OH-CZX was significantly greater, the terminal t 1/2 was significantly longer, the C max was significantly higher, the Ae 0-24 h of both total and free OH-CZX was significantly larger, and the AUC OH-CZX /AUC CZX ratio was significantly greater than those in controls. Interestingly, in LCD rats, the AUC, C max , Ae 0-24 h of total OH-CZX, and AUC OH-CZX /AUC CZX ratio were similar to those in control rats. OH-CZX was also undetectable in GI 24 h for all rats studied.
The ratios of Ae 0-24 h , conjugated OH-CZX to Ae 0-24 h , total OH-CZX were 0.638, 0.439, 0.577, and 0.405 for the control, LC, DM, and LCD rats, respectively, suggesting that formation of conjugated OH-CZX decreased considerably in LC and LCD rats compared with control and DM rats. CZX was excreted in the 24-h urine samples as the free (unconjugated) form.
Pharmacokinetics of CZX and OH-CZX after Oral Administration of CZX. The mean
arterial plasma CZX concentration-time profiles for the oral administration of CZX (50 mg/kg) are shown in Fig. 4A , and the relevant pharmacokinetic parameters are listed in administration, CZX was rapidly absorbed; in all four groups of rats, it was detected in plasma at the first blood sampling time (5 min) and rapidly reached T max within 5-45 min. In LC rats, the AUC of CZX was significantly greater and the terminal t 1/2 was significantly longer than in the control rats. In DM rats, the AUC of CZX was significantly smaller, the terminal t 1/2 was significantly shorter, the Cl r was significantly faster, and the Ae 0-24 h was significantly greater than in the control rats. Interestingly, in LCD rats, the AUC, terminal t 1/2 , C max , and Cl r of CZX were similar to those in the controls.
The mean arterial plasma OH-CZX concentration-time profiles for the oral administration of CZX are shown in Fig. 4B , and the relevant pharmacokinetic parameters are listed in Table 4 .
OH-CZX formed rapidly after oral administration of CZX; in all four groups of rats, it was detected in plasma at the first blood sampling time (5 min) and rapidly reached T max within 5-90 min. In LC rats, the terminal t 1/2 of OH-CZX was significantly longer, the C max was significantly lower, the T max was significantly longer, the Ae 0-24 h of both total and free OH-CZX was significantly smaller, and the AUC OH-CZX /AUC CZX ratio was significantly smaller than those in controls. In DM rats, the AUC of OH-CZX was significantly greater, the C max was significantly higher, the Ae 0-24 h of both total and free OH-CZX was significantly greater, and AUC OH-CZX /AUC CZX ratio was significantly greater than those in controls. Interestingly, in LCD rats, the AUC, terminal t 1/2, C max , T max , and Ae 0-24 h of total OH-CZX and the AUC OH-CZX /AUC CZX ratio were similar to those in the control rats.
The ratios of Ae 0-24 h , conjugated OH-CZX to Ae 0-24 h , total OH-CZX were 0.561, 0.553, 0.562, and 0.458 for the control, LC, DM, and LCD rats, respectively, suggesting that the formation of conjugates of OH-CZX decreased considerably in LCD rats compared with the other rats. CZX was also excreted in the 24-h urine sample as the free (unconjugated) form.
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Discussion
The presence of liver cirrhosis and diabetes mellitus in LCD rats was apparent by their significantly decreased body weight gain, significantly higher blood glucose level, significantly larger 24-h urine output, significantly higher plasma levels of GOT, GPT, alkaline phosphatase, and LDH, and significantly lighter and heavier relative liver and kidney weights, respectively, compared with control rats (Tables 1, 3 , and 4). Liver cirrhosis was also proven, based on histology, as explained in the Results section. Baek et al., (2006) reported that the Cl nr of CZX could represent the metabolic clearance of the drug in rats. Additionally, the Cl nr of CZX listed in Table 3 could represent the hepatic metabolic clearance of CZX. Thus, changes in the Cl nr of CZX could represent changes in hepatic metabolism of CZX via CYP2E1 in rats.
Pathological conditions such as diabetes ( Fig. 1) (Kim et al., 2005) and starvation (Johansson et al., 1990) induce CYP2E1. Pathological production of ketone bodies might be responsible for this induction of CYP2E1, presumably as the result of an adaptive response (Tu et al., 1983; Lieber, 1997) . Nevertheless, ketone body production does not completely account for CYP2E1 induction. A previous study showed that, in the absence of insulin, ketone bodies at concentrations up to 10 mmol/L failed to affect or produced a decrease in mRNA levels of CYP2E1 (Woodcroft et al., 2002) , which supports the concept that the induction of CYP2E1 in diabetes or during fasting is not the result of elevated circulating ketone bodies levels. Another study indicated that alterations in energy metabolism (e.g., mitochondrial dysfunction) were associated with induction of CYP2E1 (Chung et al., 2001) . We found that the hepatic CYP2E1 level was moderately greater in LCD rats than in control rats (Fig. 1) . However, the relative Cl int of CZX was comparable for the two groups (Table 2) , which may be due to the accumulation of After intravenous administration of CZX, the AUC of CZX was significantly greater in LC rats (57.0% increase) than in the control rats, possibly as a result of the significantly slower Cl of CZX (38.2% decrease) in the LC rats (Table 3 ). The slower Cl was attributable to a significantly slower Cl nr of CZX (37.5% decrease) in the LC rats, because the two groups had comparable Cl r values ( Table 3 ). The AUC of OH-CZX was significantly smaller (70.6% decrease) in LC rats than in controls (Table 3) . These results could have been due to a significantly slower (96.9% decrease) relative Cl int for the formation of OH-CZX, based on total liver, because both the content and total liver protein of CYP2E1 were considerably decreased (by 78 and 67.6%, respectively, compared with the controls) ( Table 2 , Fig. 1 ). The significantly smaller formation (AUC) of OH-CZX in LC rats could also be supported by their smaller AUC OH-CZX / AUC CZX ratio (82.0% decrease) (Table 3) .
In contrast to LC rats, DM rats exhibited a significant (57%) decrease in AUC of CZX after intravenous administration of CZX, compared with the controls, possibly because the Cl in LC rats was significantly faster (by 121%) than in the controls (Table 3 ). The faster Cl was attributable to a significantly faster (by 119%) Cl nr of CZX than in the controls (Table 3) .
Although Cl r of CZX was significantly faster (by 146%) in DM rats than in the control rats, the contribution of the Cl r to the Cl of CZX was almost negligible, constituting only 3.24% in DM rats (Table 3 ). The AUC of OH-CZX was significantly greater (by 75.1%) in DM rats than in the controls (Table 3) . These results could have been caused by an increased (by 541%) relative Cl int for the formation of OH-CZX, based on total liver, which could have been the result of the significantly higher (by 258%) content of CYP2E1 in the DM rats, despite their significantly lower (by 35.9%) total liver protein, compared with the controls (Table 2 , Fig. 1) . Thus, the contribution of the increased content of CYP2E1 to CZX metabolism and OH-CZX formation AUC OH-CZX / AUC CZX ratio compared with that in the control rats (Table 3) .
Similar results for the pharmacokinetics of CZX and OH-CZX and for Cl int per mg protein have been reported for other rat studies (Baek et al., 2006) . Also, Wang et al. (2003) reported that following oral administration of 500 mg of CZX to patients with type I diabetes or obese, type II diabetes, the AUC of CZX was reduced by 25 and 70%, respectively, compared with that in healthy volunteers. However, the urinary recovery of CZX did not differ significantly between the three groups. Wang et al. (2003) also reported increased mRNA levels for CYP2E1 in peripheral blood mononuclear cells in both types of diabetes.
Protien expression of CYP2E1 was significantly increased in DM and LCD rats and was decreased in LC rats, compared with the controls (Fig. 1) . Although the protein expression of hepatic CYP2E1 was increased (by 124%) in the LCD rats, compared with that in the control rats (Fig. 1) , the total liver protein in the LCD rats was significantly reduced (by 61.7%) ( Table 2) . As a result, the relative Cl int for the formation of OH-CZX, based on whole liver, in LCD rats was similar to that of the control rats, with a difference of only 13% (Table 2) . Thus, some pharmacokinetic parameters of CZX and OH-CZX would be expected to be similar in LCD and control rats. As expected, the AUC, MRT, Cl, Cl r , and Cl nr of CZX, and the AUC and C max of OH-CZX, the Ae 0-24 h of total OH-CZX, and the AUC OH-CZX / AUC CZX ratio did not differ significantly between control and LCD rats (Table 3) .
After oral administration of CZX, the AUC of CZX was significantly greater in LC rats and smaller in DM rats than in control or LCD rats (Table 4) . However, this finding was not likely due to result from the increase or decrease in gastrointestinal absorption of CZX found in LC and DM rats, respectively, compared with the control and LCD rats, since the GI 24 h values were This article has not been copyedited and formatted. The final version may differ from this version. undetectable for both groups after intravenous and oral administration of CZX (Tables 3 and 4) .
CZX was stable in rat gastric and intestinal fluids (Baek et al., 2006) . Thus, CZX was almost completely absorbed in all groups of rats. Similar results were obtained from our intravenous studies (Table 3) , especially for the AUC values of CZX and OH-CZX (Table 4 ). The F of CZX in LC rats was considerably greater than in the control, DM, and LCD rats (by 45.3, 63.6, and 28.5%, respectively; Table 4 ). This result could have primarily been due to the decreased hepatic metabolism of CZX in LC rats.
Although CYP2E1 is the major enzyme that metabolizes CZX to OH-CZX, human CYP1A1/2 and/or CYP3A4 (Carriere et al., 1993; Shimada et al., 1993; Gorski et al., 1997; Ono et al., 1997) and rat CYP1A1 and CYP3A1/2 (Jayyosi et al., 1995) have also been reported to carry out CZX hydroxylation. The role of CYP3A2 in the formation of OH-CZX in rats was measured by treatment with DDT (an inducer of CYP3A2; Sierra-Santoyo et al., 2000) . The V max , K m , and Cl int for the formation of OH-CZX were not significantly different for the DDT-treated vs.
the control rats, indicating that the effect of CYP3A2 on the formation of OH-CZX was almost negligible (Sierra-Santoyo et al., 2000) . Li et al. (1995) reported that treatment of rats with DDT had no effect on CYP2E1. We recently found (our unpublished data) that the protein expression of both CYP1A and CYP3A was increased in DM rats and decreased in LC rats, but in LCD rats, CYP1A was increased, whereas CYP3A was decreased.
In summary, after intravenous (Table 3) and oral (Table 4 ) administration of CZX, the AUC of OH-CZX was significantly smaller in LC rats than in control rats because protein expression of CYP2E1 and total liver protein were both decreased in the LC rats (Fig. 1) . However, the AUC of OH-CZX was significantly greater in DM rats than in control rats because of the increased protein expression of CYP2E1 in DM rats (Fig. 1) . The LCD and control rats had comparable values for AUC of OH-CZX, which may have resulted from the decrease in total liver protein in LCD rats This article has not been copyedited and formatted. The final version may differ from this version. e Control group, LC group, and DM and LCD groups were significantly different (p < 0.05).
f Control and DM groups were significantly different (p < 0.05) from LC and LCD groups.
g LC group was significantly different (p < 0.05) from LCD group.
h Below the detection limit.
i Control group, LC and LCD groups, and DM group were significantly different (p < 0.05).
j Control and DM groups were significantly different (p < 0.05) from LCD group.
k Control and LC groups, DM group, and LCD group were significantly different (p < 0.05).
Liver weight (% of body weight) b Control group, LCD group, and LC and DM groups were significantly different (p < 0.05).
c Control, DM, and LCD groups were significantly different (p < 0.05) from LC group.
d Control and LCD groups, LC group, and DM group were significantly different (p < 0.05).
e Control, LC, and LCD groups were significantly different (p < 0.05) from DM group, and LC group was significantly different (p < 0.05) from LCD group. f Control group, DM group, and LC and LCD groups were significantly different (p < 0.05). 
